🔎 Trials Near Me

Home › Cystic Fibrosis › NCT06837181

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

RecruitingObservational study

Who can join

Ages 12 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative
* For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)
* Be willing and able to adhere to the study protocol requirements
* Age ≥ 12 years at time of enrollment
* CF diagnosis based on two CF causing mutations and/or positive sweat test according to CFF diagnostic criteria
* CFRD diagnosis ≥ 5 years at time of enrollment

Exclusion Criteria:

* History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject
* History of transplant
* Pregnancy reported by participant at time of consent or at any point during active study participation

Pulse Wave Velocity Exclusion Criteria:

* Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias
* Carotid or aortic valve stenosis
* Peripheral artery disease or leg artery disease
* Generalized constriction or localized spasm of muscular conduit arteries such as seen immediately after hypothermic cardiopulmonary bypass surgery or accompanying Raynaud's phenomena or intense cold.
* Possible exclusions based on investigator medical provider assessment (additional precautions may be followed to allow inclusion):

  * Pressure reading should not be conducted on a limb where there is intravenous access, arterio-venous shunt, or where circulation is compromised.
  * Pressure reading should not be conducted on the side of the body that a mastectomy was done.

About the study

This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF.

The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.

What is being tested

Sponsor: Jaeb Center for Health Research · Participants: 200 · Started: Sep 18, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06837181

Locations in the U.S.

AlabamaUniversity of Alabama at Birmingham, Birmingham (Not yet recruiting)
CaliforniaKeck Medical Center of USC, Los Angeles (Not yet recruiting)
Stanford University, Palo Alto (Not yet recruiting)
University of California San Diego, San Diego (Not yet recruiting)
ColoradoUniversity of Colorado Denver, Aurora
FloridaUniversity of Miami, Miami (Not yet recruiting)
GeorgiaEmory University School of Medicine, Atlanta
IowaUniversity of Iowa, Iowa City (Not yet recruiting)
LouisianaTulane University, New Orleans (Not yet recruiting)
MassachusettsMassachusetts, Boston (Not yet recruiting)
MinnesotaUniversity of Minnesota, Minneapolis
New MexicoUniversity of New Mexico, Albuquerque (Not yet recruiting)
New YorkColumbia University Cystic Fibrosis Program, New York (Not yet recruiting)
North CarolinaAtrium Health Wake Forest Baptist (Wake Forest Baptist), Winston-Salem (Not yet recruiting)
PennsylvaniaThe Children's Hospital of Philadelphia, Philadelphia
South CarolinaMedical University of South Carolina, Charlestone (Not yet recruiting)
TexasBaylor College of Medicine, Houston (Not yet recruiting)
The University of Texas Health Science Center at San Antonio, San Antonio

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.